Cost-Utility Analysis Of Fidaxomicin Compared To Vancomycin In The Management Of Severe Clostridium Difficile Infection In Poland
Nov 1, 2014, 00:00
10.1016/j.jval.2014.08.828
https://www.valueinhealthjournal.com/article/S1098-3015(14)02758-2/fulltext
Title :
Cost-Utility Analysis Of Fidaxomicin Compared To Vancomycin In The Management Of Severe Clostridium Difficile Infection In Poland
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)02758-2&doi=10.1016/j.jval.2014.08.828
First page :
A368
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
251